|

Cyclophosphamide 50mg Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • King Faisal Specialist Hospital & Research Center1

Indications

  • Acute Lymphoblastic Leukemia (ALL) in Complete Remission1
  • Acute Myeloid Leukemia (AML) in Remission1
  • Cancer1

Other1 trial

Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.